About this Journal Submit a Manuscript Table of Contents
ISRN Dermatology
Volume 2012 (2012), Article ID 158598, 6 pages
http://dx.doi.org/10.5402/2012/158598
Clinical Study

Effectiveness of Keishibukuryogan on Chronic-Stage Lichenification Associated with Atopic Dermatitis

1Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama 2630, Japan
2Department of Japanese Oriental Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama 2630, Japan

Received 24 September 2012; Accepted 10 October 2012

Academic Editors: S.-C. Chao, M. Feinmesser, E. Pasmatzi, and J. F. Val Bernal

Copyright © 2012 Megumi Mizawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Y. M. Leung, M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid, “New insights into atopic dermatitis,” Journal of Clinical Investigation, vol. 113, no. 5, pp. 651–657, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Kobayashi, N. Mizuno, H. Teramae et al., “The effects of Hochu-ekki-to in patients with atopic dermatitis resistant to conventional treatment,” International Journal of Tissue Reactions, vol. 26, no. 3-4, pp. 113–117, 2004. View at Scopus
  3. H. Kobayashi, K. Takahashi, N. Mizuno, H. Kutsuna, and M. Ishii, “An alternative approach to atopic dermatitis—part I—case series presentation,” Evidence-Based Complementary and Alternative Medicine, vol. 1, no. 1, pp. 49–62, 2004.
  4. H. Kobayashi, K. Takahashi, N. Mizuno, H. Kutsuna, and M. Ishii, “An alternative approach to atopic dermatitis—part II—summary of cases and discussion,” Evidence-Based Complementary and Alternative Medicine, vol. 1, no. 2, pp. 145–155, 2004.
  5. H. M. Cheng, L. C. Chiang, Y. M. Jan, G. W. Chen, and T. C. Li, “The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial,” International Archives of Allergy and Immunology, vol. 155, no. 2, pp. 141–148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Kobayashi, M. Ishii, S. Takeuchi et al., “Efficacy and safety of a traditional herbal medicine, hochu-ekki-to in the long-term management of Kikyo (Delicate Constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 3, pp. 367–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Matsumoto, T. Kojima, K. Ogawa et al., “A proteomic approach for the diagnosis of “Oketsu” (blood stasis), a pathophysiologic concept of Japanese traditional (Kampo) medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 463–474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Fujita, T. Yamamoto, T. Kamezaki, and A. Matsumura, “Efficacy of keishibukuryogan, a traditional Japanese herbal medicine, in treating cold sensation and numbness after stroke: clinical improvement and skin temperature normalization in 22 stroke patients,” Neurologia Medico-Chirurgica, vol. 50, no. 1, pp. 1–5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Hanifin and G. Rajika, “Diagnostic features of atopic dermatitis,” Acta Dermato-Venereologica, vol. 92, supplement, pp. 44–47, 1980.
  10. A. Lyakhovitsky, A. Barzilai, R. Heyman et al., “Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults,” Journal of the European Academy of Dermatology and Venereology, vol. 24, no. 1, pp. 43–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Nozaki, H. Hikiami, H. Goto, T. Nakagawa, N. Shibahara, and Y. Shimada, “Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo formula, decreases disease activity and soluble vascular adhesion molecule-1 in patients with rheumatoid arthritis,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 3, pp. 359–364, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Tanikawa, H. Goto, N. Nakamura et al., “Endothelium-dependent vasodilator effect of tannin extract from Cinnamonomi Cortex on isolated rat aorta,” Journal of Traditional Medicines, vol. 16, no. 1, pp. 45–50, 1999.
  13. T. Makino, M. Fuiruichi, H. Watanabe, Y. Yoshihisa, and T. Shimizu, “Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo formula decreases the disease activity and the level of serum thymus and activation-regulated chemokine (TARC) in patients with atopic dermatitis,” Journal of Traditional Medicines, vol. 24, no. 1, pp. 168–170, 2007.
  14. H. Saeki and K. Tamaki, “Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases,” Journal of Dermatological Science, vol. 43, no. 2, pp. 75–84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Itoh, K. Terasawa, K. Kohta, N. Shibahara, H. Tosa, and Y. Hiyama, “Effects of Keishi-bukuryo-gan and Trapidil on the microcirculation in patients with cerebro-spinal vascular disease,” Journal of Medical and Pharmaceutical Society for WAKAN-YAKU, vol. 9, pp. 40–46, 1992.
  16. H. Hikiami, H. Goto, N. Sekiya et al., “Comparative efficacy of Keishi-bukuryo-gan and pentoxifylline on RBC deformability in patients with “oketsu” syndrome,” Phytomedicine, vol. 10, no. 6-7, pp. 459–466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Kohta, H. Hikiami, Y. Shimada, H. Matsuda, T. Hamazaki, and K. Terasawa, “Effects of Keishi-bukuryo-gan on erythrocyte aggregability in patients with multiple old lacunar infarction,” Journal of Medical and Pharmaceutical Society for WAKAN-YAKU, vol. 10, pp. 251–259, 1993.
  18. H. Tosa, K. Toriizuka, and K. Terasawa, “The effect of Keishi-bukuryogan on blood viscosity and blood coagulation in normal subjects,” Journal of Medical and Pharmaceutical Society for WAKAN-YAKU, vol. 4, pp. 172–179, 1987.
  19. Y. Nagata, H. Goto, H. Hikiami et al., “Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 359282, 10 pages, 2012. View at Publisher · View at Google Scholar
  20. M. Steinhoff, A. Steinhoff, B. Homey, T. A. Luger, and S. W. Schneider, “Role of vasculature in atopic dermatitis,” Journal of Allergy and Clinical Immunology, vol. 118, no. 1, pp. 190–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Nakagawa, H. Goto, G. Hussein, H. Hikiami, N. Shibahara, and Y. Shimada, “Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats,” Diabetes Research and Clinical Practice, vol. 80, no. 1, pp. 40–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Huang, E. J. Chang, Y. Lee, J. S. Kim, S. S. Kang, and H. H. Kim, “A genome-wide microarray analysis reveals anti-inflammatory target genes of paeonol in macrophages,” Inflammation Research, vol. 57, no. 4, pp. 189–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Z. Liu, K. Q. Xie, X. Q. Ji, Y. Ye, C. L. Jiang, and X. Z. Zhu, “Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists,” British Journal of Pharmacology, vol. 146, no. 4, pp. 604–611, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Yamahara, T. Yamada, H. Kimura, T. Sawada, and H. Fujimura, “Biologically active principles of crude drugs. Anti-allergic principles of “Shoseiryu-to”—I. Effect on delayed-type allergy reaction,” Yakugaku Zasshi, vol. 102, no. 9, pp. 881–886, 1982. View at Scopus
  25. Y. Yoshihisa, M. Furuichi, M. R. Rehman, T. Makino, and T. Shimizu, “The traditional Japanese formula Keishibukuryogan inhibits the production of inflammatory cytokines by dermal endothelial cells,” Mediators of Inflammation, vol. 2010, Article ID 804298, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus